Dermira Inc (DERM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

275 MIDDLEFIELD ROAD MENLO PARK, CA 94025

Dermira, Inc. develops and commercializes dermatology therapies. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases.

Data as of 2020-04-02
Market Cap1.026 Billion Shares Outstanding54.695 Million Avg 30-day Volume92.435 Thousand
P/E Ratio Dividend Yield EPS-4.58
Price/Sales12.719 Price cash flow ratio Price free cash flow ratio-7.5
Book Value0.26 Price to Tangible Book79.93 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.061957
BETA1.48684 52-week High/Low19.48 / 5.25 Stddev0.214152
View SEC Filings from DERM instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 1 0 (0.0%)
Aggregate 13F shares on 03/31/2020: 0 0
Aggregate 13F shares on 12/31/2019: 52.042 Million 30.264 Million
Percent change: -100.00% -100.00%
Funds creating new positions:
Funds Adding to an existing position:
Funds closing out their position: 129 47
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DERM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DERM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOTT DAVID M

  • Director
0 2020-07-01 0

BASKETT FOREST

  • 10% Owner
4,294,207 2020-06-30 0

SANDELL SCOTT D

  • 10% Owner
4,294,207 2020-06-30 0

FUST MATTHEW K

  • Director
13,550 2020-06-26 4

CRAVES FRED B

  • Director
0 2020-06-17 1

NUNN JASON RALEIGH

  • Director
0 2020-06-17 1

GILBERT HALLEY E

  • Director
0 2020-06-17 3

GUGGENHIME ANDREW CFO, CBO

  • Officer
0 2020-06-11 2

KERINS PATRICK J

  • 10% Owner
8,097,725 2020-06-10 0

MCDADE MARK

  • Director
34,692 2020-05-27 1

BARRIS PETER J

  • Director
6,420 2020-05-27 0

RINGO WILLIAM R

  • Director
0 2020-05-19 1

LYONS-WILLIAMS LORI

  • Director
0 2020-05-14 2

COHEN DAVID E

0 2020-05-13 1

BAY CITY CAPITAL LLC

BAY CITY CAPITAL MANAGEMENT V LLC

BAY CITY CAPITAL FUND V, L.P.

BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.

  • 10% Owner
1,393,612 2020-03-16 0

BAUER EUGENE A CHIEF MEDICAL OFFICER

0 2020-02-20 2

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

0 2020-02-20 2

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

0 2020-02-20 2

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

0 2020-02-20 2

SEBELIUS KATHLEEN

0 2020-02-20 1

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

0 2020-02-20 1

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

0 2020-02-20 3

BALD EAGLE ACQUISITION CORP

ELI LILLY & CO

  • 10% Owner
100 2020-02-20 2

CANAAN VIII LP

CANAAN PARTNERS VIII LLC

  • 10% Owner
2,917,169 2019-12-27 0

BARRETT M JAMES

  • Director
0 2019-05-30 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
0 2019-01-22 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

CAEYMAEX EMMANUEL

  • Director
0 2016-12-21 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

HUTTON WENDE S

  • Director
0 2015-06-11 0

DRANT RYAN D

  • 10% Owner
7,489,485 2015-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments